Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques. Issue 18 (27th April 2015)
- Record Type:
- Journal Article
- Title:
- Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques. Issue 18 (27th April 2015)
- Main Title:
- Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques
- Authors:
- Rosati, Margherita
Alicea, Candido
Kulkarni, Viraj
Virnik, Konstantin
Hockenbury, Max
Sardesai, Niranjan Y.
Pavlakis, George N.
Valentin, Antonio
Berkower, Ira
Felber, Barbara K. - Abstract:
- <abstract abstract-type="author" id="abs0005"> <title id="sect0005">Abstract</title> <sec> <p id="spar0005">Live-attenuated rubella vaccine strain RA27/3 has been demonstrated to be safe and immunogenic in millions of children. The vaccine strain was used to insert SIV <italic>gag</italic> sequences and the resulting rubella vectors were tested in rhesus macaques alone and together with SIV <italic>gag</italic> DNA in different vaccine prime-boost combinations. We previously reported that such rubella vectors induce robust and durable SIV-specific humoral immune responses in macaques. Here, we report that recombinant rubella vectors elicit robust <italic>de novo</italic> SIV-specific cellular immune responses detectable for >10 months even after a single vaccination. The antigen-specific responses induced by the rubella vector include central and effector memory CD4<sup>+</sup> and CD8<sup>+</sup> T cells with cytotoxic potential. Rubella vectors can be administered repeatedly even after vaccination with the rubella vaccine strain RA27/3. Vaccine regimens including rubella vector and SIV <italic>gag</italic> DNA in different prime-boost combinations resulted in robust long-lasting cellular responses with significant increase of cellular responses upon boost. Rubella vectors provide a potent platform for inducing HIV-specific immunity that can be combined with DNA in a prime-boost regimen to elicit durable cellular immunity.</p> </sec> </abstract>
- Is Part Of:
- Vaccine. Volume 33:Issue 18(2015)
- Journal:
- Vaccine
- Issue:
- Volume 33:Issue 18(2015)
- Issue Display:
- Volume 33, Issue 18 (2015)
- Year:
- 2015
- Volume:
- 33
- Issue:
- 18
- Issue Sort Value:
- 2015-0033-0018-0000
- Page Start:
- 2167
- Page End:
- 2174
- Publication Date:
- 2015-04-27
- Subjects:
- Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0264410X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0264410X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0264410X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.vaccine.2015.02.067 ↗
- Languages:
- English
- ISSNs:
- 0264-410X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9138.628000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3270.xml